IEEE/ACM Transactions on Computational Biology and Bioinformatics最新文献

Due to their safety, high activity, and plentiful sources, antioxidant peptides, particularly those produced from food, are thought to be prospective competitors to synthetic antioxidants in the fight against free radical-mediated illnesses. The lengthy and laborious trial-and-error method for identifying antioxidative peptides (AOP) has raised interest in creating computational-based methods. There exist two state-of-the-art AOP predictors; however, the restriction on peptide sequence length makes them inviable. By overcoming the aforementioned problem, a novel predictor might be useful in the context of AOP prediction. The method has been trained, tested, and evaluated on two datasets: a balanced one and an unbalanced one. We used seven different descriptors and five machine-learning (ML) classifiers to construct 35 baseline models. Five ML classifiers were further trained to create five meta-models using the combined output of 35 baseline models. Finally, these five meta-models were aggregated together through ensemble learning to create a robust predictive model named iAnOxPep. On both datasets, our proposed model demonstrated good prediction performance when compared to baseline models and meta-models, demonstrating the superiority of our approach in the identification of AOPs. For the purpose of screening and identifying possible AOPs, we anticipate that the iAnOxPep method will be an invaluable tool.

Huntington Disease (HD) is a type of neurodegenerative disorder which causes problems like psychiatric disturbances, movement problem, weight loss and problem in sleep. It needs to be addressed in earlier stage of human life. Nowadays Deep Learning (DL) based system could help physicians provide second opinion in treating patient's disease. In this work, human Deoxyribo Nucleic Acid (DNA) sequence is analyzed using Deep Neural Network (DNN) algorithm to predict the HD disease. The main objective of this work is to identify whether the human DNA is affected by HD or not. Human DNA sequences are collected from National Center for Biotechnology Information (NCBI) and synthetic human DNA data are also constructed for process. Then numerical conversion of human DNA sequence data is done by Chaos Game Representation (CGR) method. After that, numerical values of DNA data are used for feature extraction. Mean, median, standard deviation, entropy, contrast, correlation, energy and homogeneity are extracted. Additionally, the following features such as counts of adenine, thymine, guanine and cytosine are extracted from the DNA sequence data itself. The extracted features are used as input to the DNN classifier and other machine learning based classifiers such as NN (Neural Network), Support Vector Machine (SVM), Random Forest (RF) and Classification Tree with Forward Pruning (CTWFP). Six performance measures are used such as Accuracy, Sensitivity, Specificity, Precision, F1 score and Mathew Correlation Co-efficient (MCC). The study concludes DNN, NN, SVM, RF achieve 100% accuracy and CTWFP achieves accuracy of 87%.

The analysis of protein-ligand binding sites plays a crucial role in the initial stages of drug discovery. Accurately predicting the ligand types that are likely to bind to protein-ligand binding sites enables more informed decision making in drug design. Our study, DeepLigType, determines protein-ligand binding sites using Fpocket and then predicts the ligand type of these pockets with the deep learning model, Convolutional Block Attention Module (CBAM) with ResNet. CBAM-ResNet has been trained to accurately predict five distinct ligand types. We classified protein-ligand binding sites into five different categories according to the type of response ligands cause when they bind to their target proteins, which are antagonist, agonist, activator, inhibitor, and others. We created a novel dataset, referred to as LigType5, from the widely recognized PDBbind and scPDB dataset for training and testing our model. While the literature mostly focuses on the specificity and characteristic analysis of protein binding sites by experimental (laboratory-based) methods, we propose a computational method with the DeepLigType architecture. DeepLigType demonstrated an accuracy of 74.30% and an AUC of 0.83 in ligand type prediction on a novel test dataset using the CBAM-ResNet deep learning model. For access to the code implementation of this research, please visit our GitHub repository at https://github.com/drorhunvural/DeepLigType.

Over the past few years, artificial intelligence (AI) has emerged as a transformative force in drug discovery and development (DDD), revolutionizing many aspects of the process. This survey provides a comprehensive review of recent advancements in AI applications within early drug discovery and post-market drug assessment. It addresses the identification and prioritization of new therapeutic targets, prediction of drug-target interaction (DTI), design of novel drug-like molecules, and assessment of the clinical efficacy of new medications. By integrating AI technologies, pharmaceutical companies can accelerate the discovery of new treatments, enhance the precision of drug development, and bring more effective therapies to market. This shift represents a significant move towards more efficient and cost-effective methodologies in the DDD landscape.

Single cell RNA sequencing (scRNA-seq) is a powerful tool to capture gene expression snapshots in individual cells. However, a low amount of RNA in the individual cells results in dropout events, which introduce huge zero counts in the single cell expression matrix. We have developed VAImpute, a variational graph autoencoder based imputation technique that learns the inherent distribution of a large network/graph constructed from the scRNA-seq data leveraging copula correlation ( Ccor) among cells/genes. The trained model is utilized to predict the dropouts events by computing the probability of all non-edges (cell-gene) in the network. We devise an algorithm to impute the missing expression values of the detected dropouts. The performance of the proposed model is assessed on both simulated and real scRNA-seq datasets, comparing it to established single-cell imputation methods. VAImpute yields significant improvements to detect dropouts, thereby achieving superior performance in cell clustering, detecting rare cells, and differential expression. All codes and datasets are given in the github link: https://github.com/sumantaray/VAImputeAvailability.

The escalation of antibiotic resistance underscores the need for innovative approaches to combat bacterial infections. Phage therapy has emerged as a promising solution, wherein host determination plays an important role. Phage lysins, characterized by their specificity in targeting and cleaving corresponding host bacteria, serve as key players in this paradigm. In this study, we present a novel approach by leveraging genes of phage-encoded lytic enzymes for host prediction, culminating in the development of LHPre. Initially, gene fragments of phage-encoded lytic enzymes and their respective hosts were collected from the database. Secondly, DNA sequences were encoded using the Frequency Chaos Game Representation (FCGR) method, and pseudo samples were generated employing the Variational Autoencoder (VAE) model to address class imbalance. Finally, a prediction model was constructed using the Vision Transformer(Vit) model. Five-fold cross-validation results demonstrated that LHPre surpassed other state-of-the-art phage host prediction methods, achieving accuracies of 85.04%, 90.01%, and 93.39% at the species, genus, and family levels, respectively.

Many traditional methods for analyzing gene-gene relationships focus on positive and negative correlations, both of which are a kind of 'symmetric' relationship. Biclustering is one such technique that typically searches for subsets of genes exhibiting correlated expression among a subset of samples. However, genes can also exhibit 'asymmetric' relationships, such as 'if-then' relationships used in boolean circuits. In this paper we develop a very general method that can be used to detect biclusters within gene-expression data that involve subsets of genes which are enriched for these 'boolean-asymmetric' relationships (BARs). These BAR-biclusters can correspond to heterogeneity that is driven by asymmetric gene-gene interactions, e.g., reflecting regulatory effects of one gene on another, rather than more standard symmetric interactions. Unlike typical approaches that search for BARs across the entire population, BAR-biclusters can detect asymmetric interactions that only occur among a subset of samples. We apply our method to a single-cell RNA-sequencing data-set, demonstrating that the statistically-significant BARbiclusters indeed contain additional information not present within the more traditional 'boolean-symmetric'-biclusters. For example, the BAR-biclusters involve different subsets of cells, and highlight different gene-pathways within the data-set. Moreover, by combining the boolean-asymmetric- and boolean-symmetricsignals, one can build linear classifiers which outperform those built using only traditional boolean-symmetric signals.